CorVel (NASDAQ:CRVL) Director Sells $16,016.70 in Stock

CorVel Corp. (NASDAQ:CRVL) Director R Judd Jessup sold 210 shares of the business’s stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $76.27, for a total transaction of $16,016.70. Following the sale, the director owned 122,121 shares of the company’s stock, valued at $9,314,168.67. This trade represents a 0.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

R Judd Jessup also recently made the following trade(s):

• On Tuesday, November 11th, R Judd Jessup sold 7,076 shares of CorVel stock. The stock was sold at an average price of $76.94, for a total transaction of $544,427.44.

CorVel Stock Performance

Shares of CorVel stock traded down $0.32 on Wednesday, hitting $77.23. 266,114 shares of the company’s stock were exchanged, compared to its average volume of 146,183. CorVel Corp. has a 1 year low of $70.47 and a 1 year high of $128.61. The company has a 50-day simple moving average of $77.34 and a 200-day simple moving average of $92.38. The stock has a market capitalization of $3.96 billion, a PE ratio of 39.81 and a beta of 0.98.

CorVel (NASDAQ:CRVL) last announced its earnings results on Tuesday, November 4th. The business services provider reported $0.54 EPS for the quarter. The company had revenue of $239.64 million for the quarter. CorVel had a return on equity of 32.31% and a net margin of 10.98%.

Institutional Trading of CorVel

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Xponance Inc. boosted its stake in shares of CorVel by 4.9% during the 1st quarter. Xponance Inc. now owns 2,008 shares of the business services provider’s stock worth $225,000 after purchasing an additional 94 shares during the period. Ballentine Partners LLC raised its position in CorVel by 4.2% in the 1st quarter. Ballentine Partners LLC now owns 2,531 shares of the business services provider’s stock worth $283,000 after purchasing an additional 102 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in CorVel by 0.7% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,961 shares of the business services provider’s stock worth $1,640,000 after purchasing an additional 115 shares during the last quarter. The Manufacturers Life Insurance Company boosted its position in shares of CorVel by 0.9% during the second quarter. The Manufacturers Life Insurance Company now owns 15,918 shares of the business services provider’s stock valued at $1,636,000 after buying an additional 139 shares during the period. Finally, Arizona State Retirement System grew its stake in shares of CorVel by 1.7% during the third quarter. Arizona State Retirement System now owns 9,113 shares of the business services provider’s stock valued at $706,000 after buying an additional 155 shares during the last quarter. Institutional investors own 51.36% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently commented on CRVL shares. Wall Street Zen downgraded CorVel from a “buy” rating to a “hold” rating in a research note on Saturday. Weiss Ratings reissued a “hold (c)” rating on shares of CorVel in a report on Tuesday, October 14th. One analyst has rated the stock with a Hold rating, According to MarketBeat, the company has a consensus rating of “Hold”.

About CorVel

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.